Cargando…

Horizons in cancer research. Volume 50 /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Watanabe, Hiroto S.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Science Publishers, Inc., 2012.
Colección:Horizons in cancer research ; v. 50.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • HORIZONS IN CANCER RESEARCH: VOLUME 50; HORIZONS IN CANCER RESEARCH: VOLUME 50; LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA; CONTENTS; PREFACE; Chapter 1: GALLBLADDER CANCER: ETIOLOGY, PATHOGENESIS AND TREATMENT; INTRODUCTION; Epidemiology; Pathogenesis, Etiology and Risk Factors; MANAGEMENT; GALLBLADDER CANCER SUSPECTEDPRE-OPERATIVELY; ADDITIONAL SURGICAL CONSIDERATIONS; Diagnostic Laparoscopy; Lymph Node Dissection; Bile Duct Resection; UNSUSPECTED GALLBALDDER CANCER DISCOVERED INTRAOPERATIVELY; INCIDENTAL GALLBLADDER CARCINOMA FOUND POST-OPERATIVELY ON HISTOLOGICAL SECTIONING.
  • ADVANCED UNRESECTABLE GALLBLADDER CARCINOMACONCLUSION; REFERENCES; Chapter 2: AN OVERVIEW OF DOCETAXEL APPLICATIONS AND EFFECTS; ABSTRACT; INTRODUCTION; 1. Historic Overview; 2. Chemical Composition and Mechanisms of Action; 2.1. Chemical Composition; 2.2. Mechanisms of Action; 3. Therapeutic Applications and Benefits; 4. Benefits of Docetaxel Association with OtherAnticancer Drugs; Hormonal Modulators; Other Steroids; Immunotherapy; Antiangiogenic agents; DNA interference molecules; Microtubule Network Disrupters; 5. Adverse Side Effects; 6. Development of Resistance to Docetaxel.
  • 7. Future DirectionsCONCLUSION; REFERENCES; Chapter 3: METASTATIC CANCER PAIN MANAGEMENT TO THE BONE, SPINE AND LIVER: CURRENT ISSUES, INNOVATIVE TREATMENTS AND FUTURE DIRECTIONS; ABSTRACT; INTRODUCTION; PREVALENCE AND CAUSES OF PAININ ADVANCED CANCER; MEASURING PAIN INTENSITY; PRINCIPLES OF EFFECTIVE PAIN CONTROL; UNDER-MEDICATION OF PAINFUL BONE METASTASES; A MEASUREMENT TOOL: THE PAIN MANAGEMENT INDEX; Barriers of the Pain Management Index; INNOVATIONS IN RADIATION MANAGEMENTOF CANCER RELATED PAIN; Innovations in Radiotherapy for Bone and Spine Pain; Palliative Radiotherapy for Liver Pain.
  • FUTURE DIRECTIONSCONCLUSION; REFERENCES; Chapter 4: DOCETAXEL IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA; ABSTRACT; 1. INTRODUCTION; 2. MAIN MECHANISMS OF TAXANE ACTION; 3. SAFETY PROFILE; 4. DOCETAXEL MONOTHERAPY; 5. INDUCTION CHEMOTHERAPY; 6. CONCOMITANT CHEMORADIOTHERAPY; 7. INTRA-ARTERIAL CHEMORADIOTHERAPY; 8. SECOND-LINE CHEMOTHERAPY IN RECURRENTOR METASTATIC DISEASE; 9. TREATMENT FOR LUNG METASTASIS FROM HNSCC:A PRELIMINARY STUDY OF DOCETAXELAND NEDAPLATIN [35]; 9.1. Patients and Methods; 9.2. Results; Patient Characteristics; Treatment for Lung Metastasis.
  • Survival Associated with Lung MetastasisTreatment Efficacy and Toxicity of Docetaxel-Based Chemotherapy; 10. FUTURE DIRECTIONS FOR MOLECULAR TARGETINGTHERAPIES; CONCLUSION; REFERENCES; Chapter 5: THE EFFECTS OF CYTOSKELETAL STRUCTURE CHANGES INDUCED BY DOCETAXEL ON GENE EXPRESSIONS: A VIEW FROM DIFFERENT POINTS OF DOCETAXEL FUNCTIONS; ABSTRACT; INTRODUCTION; DOCETAXEL AS AN ANTICANCER CHEMOTHERAPY DRUG; HEPATOCYTE FOR THE TOXICITY TESTING OF DRUG CANDIDATE CHEMICALS; THREE-DIMENSIONAL CULTURE OF HEPG2 CELLS; CHANGES OF DRUG METABOLISM-RELATING GENEEXPRESSIONS IN THREE-DIMENSIONAL CULTURE.